SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q3)Sep 30, 2016 | (Q2)Jun 30, 2016 | (Q1)Mar 31, 2016 | (FY)Dec 31, 2015 | (Q4)Dec 31, 2015 | (Q3)Sep 30, 2015 | (Q2)Jun 30, 2015 | (Q1)Mar 31, 2015 | (FY)Dec 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 96M | -9.04%342M | -91.79%11M | -11.31%196M | 66.23%768M | 37M | 114.86%376M | 857.14%134M | -19.93%221M | 12.68%462M |
Net income from continuing operations | --168M | 121.95%88M | -111.54%-3M | 57.29%151M | -183.17%-341M | ---62M | -497.03%-401M | 100.00%26M | 245.45%96M | 279.04%410M |
Operating gains losses | ---150M | -350.00%-30M | 9.09%12M | 117.74%11M | -442.86%-24M | --15M | --12M | --11M | -181.82%-62M | -98.08%7M |
Depreciation and amortization | --102M | 12.42%181M | 12.69%151M | 30.08%160M | 21.43%578M | --160M | 34.17%161M | 16.52%134M | -0.81%123M | 0.42%476M |
Deferred tax | ---55M | 737.50%134M | -144.07%-144M | -84.62%2M | -134.62%-61M | ---31M | 153.33%16M | -6,000.00%-59M | 110.74%13M | 91.22%-26M |
Other non cash items | --0 | 266.67%11M | -1,500.00%-434M | -1,470.00%-137M | 109.78%27M | ---17M | -75.00%3M | 63.16%31M | 400.00%10M | -762.50%-276M |
Change In working capital | --31M | 16.67%42M | 553.85%59M | 3.80%82M | 130.07%46M | ---56M | 325.00%36M | 91.82%-13M | -29.46%79M | -42.99%-153M |
-Change in receivables | --55M | 150.00%35M | -137.88%-25M | 143.75%7M | 576.47%115M | --51M | 153.85%14M | -50.00%66M | 85.05%-16M | -26.09%17M |
-Change in inventory | ---17M | 184.00%71M | 105.00%2M | -71.23%21M | 112.37%12M | ---46M | 132.89%25M | -17.65%-40M | 69.77%73M | -212.90%-97M |
-Change in prepaid assets | ---- | ---- | 166.67%8M | -138.24%-13M | 158.49%31M | ---- | ---- | 150.00%3M | 440.00%34M | -960.00%-53M |
-Change in payables and accrued expense | --22M | -270.59%-126M | 308.22%152M | 150.00%32M | -16,900.00%-170M | --1M | -142.50%-34M | 72.03%-73M | -131.07%-64M | 98.85%-1M |
-Change in other current assets | ---6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Change in other current liabilities | ---23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Change in other working capital | ---- | -16.18%57M | -351.61%-78M | -32.69%35M | 405.26%58M | ---93M | 553.33%68M | 210.00%31M | 360.00%52M | -171.43%-19M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | --96M | -9.04%342M | -91.79%11M | -11.31%196M | 66.23%768M | --37M | 114.86%376M | 857.14%134M | -19.93%221M | 12.68%462M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 246M | -54.35%-71M | 23,466.67%707M | 548.46%583M | -284.10%-915M | -742M | -177.97%-46M | 121.43%3M | 66.58%-130M | 178.76%497M |
Capital expenditure reported | ---103M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net PPE purchase and sale | ---- | 6.85%-68M | 1,080.00%686M | 623.85%571M | -8.41%-451M | ---199M | 27.00%-73M | 20.45%-70M | -23.86%-109M | 28.64%-416M |
Net intangibles purchase and sale | ---- | 6.25%-15M | ---- | ---- | -52.17%-70M | ---35M | -14.29%-16M | ---- | ---- | -9.52%-46M |
Net business purchase and sale | --308M | ---- | ---- | ---- | -154.11%-487M | ---- | ---- | ---- | ---- | --900M |
Net investment purchase and sale | ---9M | -33.33%-4M | 0.00%-3M | -20.00%-6M | 0.00%-16M | ---5M | 25.00%-3M | 0.00%-3M | 0.00%-5M | -6.67%-16M |
Net other investing changes | --5M | -65.22%16M | -44.21%53M | 212.50%18M | 45.33%109M | ---16M | -74.01%46M | -5.94%95M | 94.59%-16M | 733.33%75M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --246M | -54.35%-71M | 23,466.67%707M | 548.46%583M | -284.10%-915M | ---742M | -177.97%-46M | 121.43%3M | 66.58%-130M | 178.76%497M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -325M | 88.24%-4M | -233.33%-20M | -137.39%-527M | 92.43%-64M | 198M | 88.82%-34M | 96.61%-6M | -170.48%-222M | -1,900.00%-846M |
Net issuance payments of debt | --0 | 86.67%-4M | 48.72%-20M | -1,590.32%-524M | -67.91%103M | --203M | 28.57%-30M | 93.96%-39M | -103.20%-31M | 129.10%321M |
Net common stock issuance | ---302M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net other financing activities | ---23M | --0 | --0 | 98.43%-3M | 85.69%-167M | ---5M | 98.47%-4M | -92.96%33M | 70.84%-191M | -201.48%-1.17B |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---325M | 88.24%-4M | -233.33%-20M | -137.39%-527M | 92.43%-64M | --198M | 88.82%-34M | 96.61%-6M | -170.48%-222M | -1,900.00%-846M |
Net cash flow | ||||||||||
Beginning cash position | --1.12B | 209.94%1.09B | 77.83%393M | -59.94%141M | 47.28%352M | --648M | 33.33%352M | -49.89%221M | 47.28%352M | -42.13%239M |
Current changes in cash | --17M | --267M | --698M | 292.37%252M | -286.73%-211M | ---507M | ---- | ---- | -164.85%-131M | 164.94%113M |
End cash Position | --1.13B | 109.57%1.36B | 209.94%1.09B | 77.83%393M | -59.94%141M | --141M | 234.02%648M | 33.33%352M | -49.89%221M | 47.28%352M |
Free cash flow | --38M | -9.76%259M | -515.56%-187M | -13.39%97M | --247M | ---197M | 370.49%287M | 145.92%45M | -40.43%112M | --0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion |